The deal comes after the Supreme Court blocked a controversial bankruptcy plan for Purdue that shielded Sackler family members from future lawsuits.
Purdue was instrumental in creating the US opioid crisis via aggressive marketing that did not reflect the true addiction risks of its drugs, particularly OxyContin (oxycodone). Many other creditors ...